Publications dans lesquelles il/elle collabore avec JUAN TORRES MACHO (13)

2024

  1. Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors

    Viruses, Vol. 16, Núm. 2

2022

  1. Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care

    Liver International, Vol. 42, Núm. 2, pp. 309-319

  2. Misdiagnosis rate among negative COVID-19 patients in real-life with Panbio COVID-19 antigen rapid test during 2021

    Journal of Infection

  3. Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors

    Respiration, Vol. 101, Núm. 7, pp. 658-665

2021

  1. Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

    Frontiers in Medicine, Vol. 8

  2. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain

    International Journal of Drug Policy, Vol. 96

  3. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study

    International Journal of Drug Policy, Vol. 92

  4. HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study

    Infectious Diseases of Poverty, Vol. 10, Núm. 1

  5. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  6. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study

    Thrombosis Research, Vol. 199, pp. 132-142

  7. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. The pandemyc score. An easily applicable and interpretable model for predicting mortality associated with COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-10